Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1

Status

Completed 3Terminated 1Available 1Active not recruiting 1

Sponsor Class

OTHER 3OTHER_GOV 2INDUSTRY 1

Study Type

Interventional 3Observational 2Expanded_access 1

Sponsor

Cancer Type

Gastrointestinal 6Sarcoma 1Lymphoid 1Gynecologic 1Genitourinary 1CNS 1Breast 1

Conditions

Stomach Neoplasms 6Neoplasms 2Lymphoma, Non-Hodgkin 2Helicobacter Infections 2Gastroesophageal Reflux 2Breast Neoplasms 2Barrett Esophagus 2Squamous Cell Carcinoma of Head and Neck 1Spinal Cord Compression 1Small Cell Lung Carcinoma 1Sarcoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Persistence of Infection With Helicobacter Pylori 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Non-Erosive Reflux Disease 1Neoplasm Metastasis 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Lung Neoplasms 1Hodgkin Disease 1Hemorrhage 1Head and Neck Neoplasms 1Glioblastoma 1Gastritis, Atrophic 1Fatigue 1Familial primary gastric lymphoma 1Esophageal Neoplasms 1Delayed Bleeding 1

Interventions

Oxaliplatin 295Capecitabine 209Fluorouracil 183Cisplatin 172Docetaxel 140S 1 (combination) 135Paclitaxel 128Leucovorin 117Irinotecan 110pembrolizumab 104Trastuzumab 76Nivolumab 59apatinib 57Drug Therapy 52sintilimab 46Surgical Procedures, Operative 45Ramucirumab 40Radiotherapy 40Bevacizumab 37Hyperthermic Intraperitoneal Chemotherapy 34Epirubicin 32titanium silicide 31tislelizumab 31Carboplatin 31Gastrectomy 28Cyclophosphamide 27XELOX 25Tegafur 24Folfox protocol 23Albumin-Bound Paclitaxel 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Stomach Neoplasms × Proton Pump Inhibitors × Clear all
NCT05974410 2025-10-02

Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients

AVM Biotechnology Inc

Available
BreastCNSGastrointestinalGenitourinaryGynecologicLymphoidSarcoma

Brain Neoplasms, Breast Neoplasms, Carcinoma, Squamous Cell, Glioblastoma, Hodgkin Disease, Lymphoma, Non-Hodgkin, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms

NCT05688761 2024-06-24

NordGETS

Karolinska Institutet

Completed
900,000 enrolled
Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms

NCT02407119 2023-11-09

Effects of H. Pylori Eradication on the Gastric Preneoplastic Lesion and Neoplasm After ESD

National Cancer Center, Korea

Phase 3 Active not recruiting
470 enrolled
Gastrointestinal

Atrophy, Stomach Neoplasms

NCT02150447 2018-04-04

The Use of Proton Pump Inhibitor on the Prevention of Gastric Cancer Bleeding

National Cancer Center, Korea

Phase 3 Terminated
394 enrolled
Gastrointestinal

Hemorrhage, Stomach Neoplasms

NCT02449941 2016-12-06

Helicobacter Pylori and Proton Pump Inhibitor

Asan Medical Center

Completed
30 enrolled
Gastrointestinal

Gastritis, Atrophic, Stomach Neoplasms, Helicobacter Infections

NCT02254889 2016-02-12

Pain After Endoscopic Submucosal Dissection

Gangnam Severance Hospital

Phase NA Completed
156 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡